National Health (Pharmaceutical Benefits) Regulations (Amendment)

Overview

The Statutory Rules 1978 No. 153, made under the National Health Act 1953, introduce amendments to the National Health (Pharmaceutical Benefits) Regulations. These amendments were enacted to address gaps in the existing regulation of pharmaceutical benefits, particularly in the areas of prescription handling and the supply of pharmaceutical benefits. The regulations were made by the Governor-General of Australia, acting with the advice of the Federal Executive Council, to ensure compliance with the overarching objectives of the National Health Act. The policy objective of these amendments is to provide more flexibility and efficiency in the dispensing of pharmaceutical benefits, allowing for deferred supply authorizations and modifications to the handling and retention of prescriptions.

Scope and Application

The National Health (Pharmaceutical Benefits) Regulations 1978, as amended, apply to various entities within the pharmaceutical industry, particularly approved pharmaceutical chemists and individuals involved in the prescription and supply of pharmaceutical benefits. The regulations govern the conduct and transactions related to the supply of pharmaceutical benefits under the National Health Act 1953, with a particular focus on the management and deferral of supplies for multiple pharmaceutical benefits. These regulations operate within the Commonwealth jurisdiction and apply across Australia, ensuring a consistent approach to the handling of pharmaceutical benefits nationwide. Notably, these regulations do not explicitly state any exclusions or exemptions, but they do provide specific conditions under which deferral of supply is permissible. The regulations are further extended through subordinate instruments to cover additional aspects of pharmaceutical benefit supply, such as the creation and management of deferred supply authorizations, ensuring a comprehensive framework for the sector.

Key Provisions

The Regulations under the National Health Act 1953 include several amendments to the National Health (Pharmaceutical Benefits) Regulations, primarily focusing on the writing of prescriptions and the supply of pharmaceutical benefits. Regulation 19 removes the requirement for prescriptions to be marked in accordance with regulation 20, while Regulation 21 updates the supply of pharmaceutical benefits on prescription to include regulations 22, 26, and 26a. Regulation 26 is amended to allow for the use of duplicate prescriptions with deferred supply authorizations. A new regulation, 26a, is introduced, which allows for the deferral of the supply of one or more pharmaceutical benefits where a prescription contains a direction to supply more than one pharmaceutical benefit. The approved pharmaceutical chemist must prepare a deferred supply authorization, mark it with their approval number, and attach it to the duplicate of the prescription. These regulations impose specific obligations on approved pharmaceutical chemists. They must prepare and issue deferred supply authorizations as per regulation 26a, marking these with their approval number and the pension number for pensioners. They must also mark the original and duplicate prescriptions with the words "original supply deferred" and retain the duplicate of the deferred supply authorization for at least one year. The Regulations are clear about the process and documentation required for deferring the supply of pharmaceutical benefits. Breaches of these regulations may result in civil or criminal consequences. However, the specific offences, penalties, or consequences for non-compliance are not detailed within the provided text of the Regulations. The penalties for breaches of regulations under the National Health Act 1953 would typically be outlined in the Act itself or in other related legislative instruments. It is essential for approved pharmaceutical chemists to adhere to these regulations to avoid any potential legal repercussions.